期刊
JOURNAL OF PERINATOLOGY
卷 41, 期 4, 页码 661-674出版社
SPRINGERNATURE
DOI: 10.1038/s41372-021-01022-9
关键词
-
Neonatal encephalopathy has a significant impact on newborn survival and neurodevelopmental outcomes, with therapeutic hypothermia being the established standard treatment. Despite therapeutic hypothermia, a proportion of infants still suffer long-term disabilities from brain injury. Innovative therapies may offer the possibility of further improving neurodevelopmental outcomes.
Neonatal encephalopathy (NE) continues to have a major impact on newborn survival and neurodevelopmental outcomes worldwide. In high-income settings, therapeutic hypothermia is the only established standard treatment for neonates with moderate-to-severe NE, with compelling evidence that cooling reduces mortality and major neurodevelopmental impairment in survivors. Despite therapeutic hypothermia, a significant proportion of cooled infants continue to suffer long-term disability from brain injury. Innovative therapies offer the possibility of further improving neurodevelopmental outcomes by working synergistically with therapeutic hypothermia to decrease hypoxia-ischemia-induced excitotoxicity, prevent progression to secondary energy failure, and in some cases, promote neuroregeneration in the developing neonatal brain. This review discusses emerging NE therapies currently under investigation, offers insight into controversies surrounding various approaches to clinical care during therapeutic hypothermia, and identifies ongoing knowledge deficits that hinder attainment of optimal outcomes for neonates with NE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据